| Literature DB >> 34753746 |
Fawzia N Rasheed1, Jerome Baddley2, Poornima Prabhakaran3, Enrique Falceto De Barros4,5, K Srinath Reddy6, Nelzair Araujo Vianna7, Robert Marten8.
Abstract
Entities:
Mesh:
Year: 2021 PMID: 34753746 PMCID: PMC8576604 DOI: 10.1136/bmj.n1284
Source DB: PubMed Journal: BMJ ISSN: 0959-8138
Healthcare sector emissions by country economic classification4
| Income group | No of countries with data | Average (range) CO2 intensity (kgCO2e/$) |
|---|---|---|
| Low income | 0 | 0 |
| Lower middle income | 7 | 1.44 (0.5-3.9) |
| Upper middle income | 17 | 0.87 (0.23-2.08) |
| Low and middle income | 24 | 1.03 (0.23-3.9) |
| High income | 37 | 0.38 (0.07-2.09) |
Examples of opportunities to act to reduce emissions
|
|
|
|
|
|
|
| Calculate carbon footprint using newly available tools | Investment cost in staff time | Essential first step to targeted action and initiation of cross-organisational and systemic engagement | |
| Further strengthen WHO support for environmental sustainability | Improve evidence informed policy | Efficiently and effectively coordinate global efforts to decarbonise healthcare | ||
| Shift from hospital centric to community and preventive care | Lower healthcare costs | Fewer emissions associated with healthcare facilities | Increased focus on prevention and timely access to care | |
| Comply with the healthcare professionals’ call for a healthy recovery from covid 19 | Cumulative global gross domestic product gains of $98tn between now and 2050 | Reduced carbon emissions, air pollution, water pollution, and nature degradation | Respiratory, cardiovascular, cancer, foetal development, infant birth outcomes, and more | |
|
| LED (light emitting diode) lighting and lighting controls | Up to 85% less expensive to run | Up to 85% less CO2. Avoids use of mercury in fluorescent lights | Emit less UV, attract fewer insects, less vector borne illness risk |
| Battery power (on-grid sites) | Lower cost to run than petrol generators | Less CO2, air pollution, and noise Although mining impacts LMICs | Less air pollution, noise, occupational health risk | |
| Efficient cooling | Inverter driven AC units can cost 50% less to run | Less CO2 from electricity use and refrigerants leaks | Essential cooling becomes more affordable | |
| Solar photovoltaic (off-grid sites) | Lower running cost than off-grid petrol generators | Far fewer carbon emissions, air pollution, and noise | Less air pollution, noise, occupational health risk | |
|
| Optimise video conferencing post-covid 19 | Efficient use of staff time, healthcare facilities, lower fuel costs | Lower CO2 from transport and healthcare facilities | Less burden to staff from travel. More time for healthcare |
| Accelerate shift to telehealth post-covid 1927-29 | Improved healthcare access and quality; less infection, accident risk, travel burden | |||
| Move to plug-in hybrid electric vehicles and car pooling | Lower fuel and maintenance costs | Less noise and air pollution | ||
|
| Reduce overprescribing, increase non-pharma options | Drugs and devices costs | Fewer emissions associated with pharma and supply chain | Reduced health risk of adverse drug reactions and antimicrobial resistance |
| Low carbon inhalers. Favour propellant-free devices and better condition management | Dependent on product | Avoided emissions of high carbon propellants | Improved management of respiratory conditions | |
| Low carbon anaesthetics and replacing surgical N2O with medical air/O2
| Dependent on product | Less CO2 and ozone depletion impact from anaesthetics | Less risk to healthcare staff from occupational exposure to gases | |
| Geographical sourcing to favour lower carbon country of origin | Potential to stimulate industry and governments to invest in sustainability and green growth | Some LMICs and specific companies are already decarbonising Accounting and valuing CO2 in procurement can reduce supply chain emissions and encourage wider change | Stimulating growth in cleaner, more environmentally responsible suppliers creates employment, reduced pollution, and supports the wider determinants of health | |
| Favour low CO2 suppliers | ||||
| Favour low CO2 products, packaging, and logistics | ||||
|
| Visible standards, targets, and public reporting of progress in decarbonised healthcare | Wider scale of uptake and impact from measures such as those identified above | ||
| Health professional’s engagement with national and regional professional and media networks, encouraging clear commitments with practical actions | ||||
| Health providers’ engagement with governments encouraging policy and financial incentives for carbon reduction | ||||